Purpose: To identify and assess predictors of short-term outcomes and a prolonged length of hospital stay after head and neck cancer surgery in older-old and oldest-old patients. Procedures: Patients aged ≥75 years with head and neck cancer undergoing surgery at the Brazilian National Cancer Institute from January to December 2011 were assessed regarding postoperative complications, mortality, and length of hospital stay. Results: Over the study period, 67 patients with head and neck cancer underwent surgery, 44.8% of whom developed complications within 30 days of surgery, surgical site and respiratory infections (29.9 and 20.9%, respectively) being the most common. The mean length of hospital stay was 7 days (range: 2-26). In multivariate analysis, previous radiotherapy, dependence in instrumental activities of daily living, and low serum hemoglobin (≤13.2 g/dl) were predictors of complications. In addition, the presence of at least 1 clinical or surgical complication, smoking, and an arm circumference ≤25 cm were independent predictors of a prolonged length of hospital stay. Conclusions: Complications after head and neck cancer surgery in the elderly are common and related to the prolonged length of hospital stay, both being influenced by previous radiotherapy, smoking, functional dependence in instrumental activities of daily living, and nutritional conditions. Such predictors should be considered in a preoperative assessment of elderly patients as these are modifiable risk factors.

Keywords:
Head and neck cancer, Prolonged length of hospital stay, Surgery on older-old and oldest-old patients, Functional assessment, Nutritional status, Quality of life
1.
Aaldriks AA, Maatense E, Cessie SL, et al: Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 2010;79:205-212.
2.
Molina-Garrido MJ, Guillén-Ponce C: Development of a cancer-specific Comprehensive Geriatric Assessment in a University Hospital in Spain. Crit Rev Oncol Hematol 2011;77:148-161.
3.
Ortholan C, Benezery K, Dassonville O, et al: A specific approach for elderly patients with head and neck cancer. Anticancer Drugs 2011;22:647-655.
4.
Fried LP, Guralnik JM: Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 1997;45:92-100.
5.
Mountzios G, Soultati A, Syrigos K: Multidisciplinary approach of head and neck cancer in the elderly: an update. Head Neck Oncol 2013;5:1-14.
6.
Manton KG, Corder L, Stallard E: Chronic disability trends in elderly United States populations: 1982-1994. Proc Natl Acad Sci USA 1997;94:2593-2598.
7.
Overcash JA, Beckstead J, Extermann M, et al: The abbreviated Comprehensive Geriatric Assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol 2005;54:129-136.
8.
Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
9.
Katz S, Downs TD, Cash HR, et al: Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
10.
Espinosa Domínguez E, Reveron Gómez MA, Perez Méndez L, Martinez Gimeno G, Moure Garcia E, Yanes Luque E: Factores de riesgo para las complicaciones postoperatorias en cirugía mayor de cabeza y cuello. Rev Esp Anestesiol Reanim 2011;58:218-222.
11.
Paillaud E, Bories PN, le Parco JC, et al: Nutritional status and energy expenditure in elderly patients with recent hip fracture during a 2-month follow-up. Br J Nut 2000;83:97-103.
12.
Lino VT, Pereira SR, Camacho LA, et al: Cross-cultural adaptation of the Independence in Activities of Daily Living Index (Katz Index) (in Portuguese). Cad Saude Publica 2008;24:103-112.
13.
de Freitas EV, Py L, Cançado FAX, et al: Tratado de geriatria e gerontologia, ed 2. Rio de Janeiro, Guanabara Koogan, 2006, pp 110-111.
14.
Lipschitz DA: Screening for nutritional status in the elderly. Prim Care 1994;21:55-67.
15.
Chan S, Blackburn GL: Total parenteral nutrition in cancer patients; in Heber D, Blackburn GL, Go VLW (eds): Nutritional Oncology, ed 1. San Diego, Academic Press, 1999, pp 573-586.
16.
Baker JP, Detsky AS, Wesson DE, et al: Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med 1982;306:969-972.
17.
Allareddy V, Konety BR: Characteristics of patients and predictors of in-hospital mortality after hospitalization for head and neck cancers. Cancer 2006;106:2382-2388.
18.
Velasco E, Martins CA, Gonçalves VM, Dias LF, Thuler LC: Risk factors for surgical wound infection development in head and neck cancer surgery (in Portuguese). Rev Hosp Clin Fac Med Sao Paulo 1995;50:58-62.
19.
Lee DH, Kim SY, Nam SY, et al: Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol 2011;47:528-531.
20.
Fried LP, Guralnik JM: Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc 1997;45:92-100.
21.
Kurtz JE, Heitz D, Kurtz-Illig V, Dufour P: Geriatric oncology: how far have we gone and what are the next steps? Oncology 2009;77:147-156.
22.
Overcash JA, Beckstead J, Moody L, Extermann M, et al: The abbreviated Comprehensive Geriatric Assessment (aGGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol 2006;59:205-210.
23.
Lee WR, Berkey B, Marcial V, et al: Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys 1998;42:1069-1075.
24.
Hoff CM: Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol 2012;51:419-432.
25.
Hu K, Harrison LB: Impact of anemia in patients with head and neck cancer treated with radiation therapy. Curr Treat Options Oncol 2005;6:31-45.
26.
Frederick WJ, Sweeny SC, et al: Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope 2013;123:1612-1617.
27.
Lassig AA, Yueh B, Joseph AM: The effect of smoking on perioperative complications in head and neck oncologic surgery. Laryngoscope 2012;122:1800-1808.
28.
Kuri M, Nakagawa M, Tanaka H, et al: Determination of the duration of preoperative smoking cessation to improve wound healing after head and neck surgery. Anesthesiology 2005;102:892-896.
29.
Thomas DR: Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007;26:389-399.
30.
Thomas DR: Weight loss in older adults. Rev Endocr Metab Disord 2005;6:129-136.
31.
Nilwik R, Snijders T, Leenders M, et al: The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol 2013;48:492-498.
32.
Fonseca J, Santos CA: Clinical anatomy: anthropometry for nutritional assessment of 367 adults who underwent endoscopic gastrostomy (in Portuguese). Acta Med Port 2013;26:212-218.
33.
Martin VC, Dominguez Calvo J, San Román Carbajo J, et al: Prolonged hospital stay in patient with head and neck cancer: impact of nutritional status and pharyngeal problems (in Spanish). Nutr Hosp 2004;19:150-153.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.